“Once-Daily Roflumilast Cream 0.05% for the Treatment of Atopic Dermatitis in Patients Aged 2–5 Years With Diverse Skin Types: Subgroup Analysis From the Phase 3 INTEGUMENT-PED Trial”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s745. Accessed May 1, 2026. https://skin.dermsquared.com/skin/article/view/4065.